Construction and validation of an immunoediting-based optimized neoantigen load (ioTNL) model to predict the response and prognosis of immune checkpoint therapy in various cancers.
Hyperhaploid plasma cell myeloma characterized by poor outcome and monosomy 17 with frequently co-occurring TP53 mutations.
Blood Cancer Journal
Peterson, Jess F JF; Rowsey, Ross A RA; Marcou, Cherisse A CA; Pearce, Kathryn E KE; Williamson, Cynthia M CM; Frederick, Lori A LA; Greipp, Patricia T PT; Ketterling, Rhett P RP; Kumar, Shaji S; Viswanatha, David S DS; Polley, Mei-Yin MY; Fink, James M JM; Reichard, Kaaren K KK; Van Dyke, Daniel L DL; Baughn, Linda B LB
appreci8: a pipeline for precise variant calling integrating 8 tools.
Bioinformatics (Oxford, England)
Sandmann, Sarah S; Karimi, Mohsen M; de Graaf, Aniek O AO; Rohde, Christian C; Göllner, Stefanie S; Varghese, Julian J; Ernsting, Jan J; Walldin, Gunilla G; van der Reijden, Bert A BA; Müller-Tidow, Carsten C; Malcovati, Luca L; Hellström-Lindberg, Eva E; Jansen, Joop H JH; Dugas, Martin M
Publication Date: 2018-12-15
Variant appearance in text: TP53: 748C>A; Pro250Thr
Martelotto, Luciano G LG; Ng, Charlotte Ky CK; De Filippo, Maria R MR; Zhang, Yan Y; Piscuoglio, Salvatore S; Lim, Raymond S RS; Shen, Ronglai R; Norton, Larry L; Reis-Filho, Jorge S JS; Weigelt, Britta B